White House Accelerates Psychedelic Therapies to Tackle Serious Mental Illness
TL;DR
The White House issues a policy order to speed up research, review, and potential approval of psychedelic medicines (including ibogaine) for serious mental illnesses, expanding access through Right to Try pathways, prioritizing FDA reviews for Breakthrough Therapy-designated drugs, funding federal-state collaboration, and boosting data sharing with the VA and private sector, while pursuing timely rescheduling of Schedule I substances after Phase 3 trials — all within existing laws and funding constraints, with a focus on veterans and reducing suicidality.
Topics:top-newspolitics#breakthrough-therapy#fda#mental-health#politics#psychedelic-drugs#right-to-try
- ACCELERATING MEDICAL TREATMENTS FOR SERIOUS MENTAL ILLNESS The White House (.gov)
- Trump Loosens Restrictions on Psychedelic Drugs The New York Times
- Trump signs order to speed up review of psychedelic drugs for mental health treatment NBC News
- Trump orders more access to psychedelics like LSD, psilocybin, ibogaine The Washington Post
- Trump to sign executive order on psychedelic drug used abroad to treat PTSD CBS News
Want the full story? Read the original reporting
Read on The White House (.gov)